Utah biologics regulations.

Who may administer PRP, exosomes and stem cells in Utah, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Utah?

In Utah, practitioners offering biologic treatments such as stem cell therapy should have proper licensure and be authorized healthcare providers. Only licensed physicians (MDs/DOs) with the necessary state board certifications may administer these therapies.

Official sources

Utah compliance guide.

FDA Compliance

Providers offering biologics in Utah must follow the U.S. Food and Drug Administration (FDA) guidelines for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Clinics are expected to meet FDA criteria, particularly the requirements outlined in 21 CFR Part 1271, which categorizes and regulates various HCT/Ps.

Additionally, compliance with FDA guidelines for manufacturing biologics is critical for ensuring product safety and quality.

Utah State Regulations

Utah does not currently have specific regulations for biologics beyond federal requirements. However, the Utah Department of Health provides guidance for healthcare facilities and practitioner compliance standards.

Following federal FDA standards and consulting with the Utah Department of Health is advised for comprehensive compliance with both federal and state requirements.

Provider Qualifications

In Utah, practitioners offering biologic treatments such as stem cell therapy should have proper licensure and be authorized healthcare providers. Only licensed physicians (MDs/DOs) with the necessary state board certifications may administer these therapies.

Check with the Utah Division of Occupational and Professional Licensing (DOPL) to confirm the latest requirements for licensure.

Patient Informed Consent

Utah clinics must ensure patients receive comprehensive informed consent before any biologic procedure. The consent should clearly explain:

  • The nature and purpose of the treatment
  • Potential risks and benefits
  • Alternative treatments available
  • The experimental nature of some biologic therapies

Pre-Treatment and Post-Treatment Protocols

Establishing clear pre-treatment and post-treatment protocols can help ensure patient safety and treatment consistency. It is recommended to create standardized operating procedures (SOPs) for assessing patient suitability, administering therapy, and providing post-treatment care, which can further reduce risk and enhance outcomes.

Insurance Requirements

Clinics offering biologics in Utah should verify that their medical liability insurance covers biologic therapies. Consulting with your insurance provider can help you understand specific coverage needs and avoid liability issues.

Marketing Compliance

Marketing for biologic therapies must adhere to FDA guidelines and Utah advertising regulations. Avoid misleading language, exaggerated claims, or unapproved statements about therapeutic benefits. Ensure all promotional content is factual, transparent, and includes necessary disclaimers regarding the experimental status of certain biologic treatments.

This guide is a general summary to help clinics understand compliance requirements for biologics in Utah. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Utah: common questions.

Who can administer stem cells, PRP and exosomes in Utah?
In Utah, practitioners offering biologic treatments such as stem cell therapy should have proper licensure and be authorized healthcare providers. Only licensed physicians (MDs/DOs) with the necessary state board certifications may administer these therapies. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Utah?
FDA rules are federal, so they apply in Utah as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Utah?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Utah?
Start with the live webinar, then a discovery call and live training. After that we verify your Utah licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Utah? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.